Author:
Kaspar Hanna G.,Crum Christopher P.
Reference131 articles.
1. Rabban JT, Longacre TA. Immunohistology of the female genital tract. In: Dabbs DG, editor. Diagnostic immunohistochemistry – theranostic and genomic applications. 4th ed. Philadelphia, PA: Elsevier Saunders; 2014. p. 653–709.
2. Fuehrer NE, Keeney GL, Ketterling RP, et al. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med. 2012;136(6):623–6.
3. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005;29(10):1348–55.
4. Rose PG, Cibas ES, Rose PG, Peters III WA. Cervical squamous neoplasia. In: Crum CP, Nucci MR, Lee KR, editors. Diagnostic gynecologic and obstetric pathology. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2011. p. 245–327.
5. McCluggage WG. Immunohistochemical and functional biomarkers of value in female genital tract lesions. In: Robboy SJ, Mutter GL, Prat J, Bentley R, Russell P, Anderson MC, editors. Robboy’s pathology of the female reproductive tract. 2nd ed. London: Churchill Livingstone; 2009. p. 999–1010.